EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Amgen CEO: weight loss drug can address 'patient persistence issue'
Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Yahoo News Canada
Amgen Inc. $AMGN Shares Acquired by PKO Investment Management Joint Stock Co
GRIMES & Co WEALTH MANAGEMENT LLC Trims Position in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Bought by Citizens Financial Group Inc. RI
Bogart Wealth LLC Sells 4,211 Shares of Amgen Inc. $AMGN
Amgen Calls 2026 a "Springboard Year" as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event
Amgen says MariTide helped trial patients maintain weight loss - Yahoo News Canada
Amgen to announce data on obesity drug MariTide at healthcare conference
Amgen Inc. $AMGN Shares Sold by Sumitomo Mitsui Trust Group Inc.
Amgen Buys U.K. Biotech Company
Tema Etfs LLC Boosts Stock Position in Amgen Inc. $AMGN - Daily Political
How Amgen's DISCO Oncology Licensing Deal Will Impact Amgen (AMGN) Investors
Nepsis Inc. Cuts Stock Position in Amgen Inc. $AMGN
Is It Time To Reassess Amgen (AMGN) After Its 28% One Year Share Price Gain?
State of Alaska Department of Revenue Sells 3,034 Shares of Amgen Inc. $AMGN - Stock Observer
Amgen Inc. $AMGN Stock Holdings Reduced by Nova R Wealth Inc. - Stock Observer
Amgen (NASDAQ:AMGN) Upgraded by UBS Group to "Strong-Buy" Rating - Stock Observer
Amgen (AMGN) Valuation Check After DISCO Oncology Deal And Fresh Analyst Optimism
Amgen (NASDAQ:AMGN) Price Target Raised to $319.00 at Truist Financial
Should Amgen's (AMGN) Exclusive DISCO Oncology Deal Require Action From Investors?
Amgen Inc. $AMGN Shares Acquired by HB Wealth Management LLC
Amgen Inc. $AMGN Shares Acquired by Benjamin Edwards Inc.
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE C
Industry considering options amid US vaccine upheaval | BioWorld
Amgen's $840 Million Acquisition of Dark Blue Therapeutics Boosts Cancer Drug Development, ETPharma
Why India Decided to Sharply Hike Its Tobacco Taxes: Prognosis
CX Institutional Increases Stake in Amgen Inc. $AMGN
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52
Cerity Partners LLC Sells 6,837 Shares of Amgen Inc. $AMGN
Securian Asset Management Inc. Lowers Holdings in Amgen Inc. $AMGN - Daily Political
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
)
Amgen buys Dark Blue Therapeutics for up to $840m
Amgen Buys Cancer Drug Developer Dark Blue in $840 Million Deal
/AMGEN%20Inc_%20logo%20on%20meds-by%20Melnikov%20Dmitriy%20via%20Shutterstock.jpg)
What to Expect From Amgen's Q4 2025 Earnings Report
D.A. Davidson & CO. Purchases 6,222 Shares of Amgen Inc. $AMGN
AMGN: Patent Expiries And New Drug Launches Will Shape Future Performance
Asset Management One Co. Ltd. Buys 9,753 Shares of Amgen Inc. $AMGN
Davis Capital Management Makes New Investment in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Bought by Verity & Verity LLC
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN
Mattern Capital Management LLC Buys 4,411 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Miracle Mile Advisors LLC
Amgen Inc. $AMGN Shares Acquired by Hofer & Associates. Inc - Markets Daily
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 7,600 Shares of Amgen Inc. $AMGN - Markets Daily
Amgen Inc. $AMGN Shares Bought by Ascent Group LLC
VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen Inc. $AMGN Stock Position Trimmed by Oak Asset Management LLC - Markets Daily
Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC
Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN
Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally
What They Said: Sarah Friar of OpenAI on AI
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
14 Best Pharma Dividend Stocks to Buy in 2026
Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc.
KW Wealth Management LLC Makes New $437,000 Investment in Amgen Inc. $AMGN - Daily Political
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
Amgen Inc. $AMGN Stock Holdings Lowered by Pacer Advisors Inc. - Zolmax
Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc.
Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN
Regent Peak Wealth Advisors LLC Invests $539,000 in Amgen Inc. $AMGN - Stock Observer
Secured Retirement Advisors LLC Sells 2,459 Shares of Amgen Inc. $AMGN - Stock Observer
Does FDA's UPLIZNA gMG Expansion Reshape the Bull Case for Amgen's Diversification Story (AMGN)?
Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC
Weekly Analysts' Ratings Updates for Amgen (AMGN) - Stock Observer
Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd.
Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - Daily Political
Head to Head Contrast: Amgen (NASDAQ:AMGN) & Dynavax Technologies (NASDAQ:DVAX) - Daily Political
Is There Still Value in Amgen After Its Strong 2025 Share Price Run?
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
Top Medical Stocks To Follow Today - December 21st - Markets Daily
Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements
Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC
Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COS
Takeda's AI-Driven Psoriasis Pill Shows Promising Results in Late-Stage Trials, ETPharma
Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction
Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A.
Czech National Bank Acquires 5,299 Shares of Amgen Inc. $AMGN - Daily Political
Amgen (AMGN) Valuation Check After FDA Expansion of UPLIZNA in Generalized Myasthenia Gravis
HSBC Turns More Bullish on Amgen (AMGN) into 2026
This biotech name is evolving into a major obesity play. How to trade it with options
Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc
Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease
Reichman Jorgensen Adds Snell & Wilmer's Mammen to DC Office
What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders - Simply Wall St News
